Generate a tailored SOP for Dr. Luc Berthiaume. Improve your application with a focused, well-structured draft.
Luc Berthiaume is a Professor in the Department of Cell Biology at the University of Alberta, where he focuses on the study of protein fatty acylation, a significant modification that influences various cellular processes, including membrane targeting, apoptosis, and cellular proliferation. His research highlights the role of fatty acylated proteins, which make up an abundant yet under-researched family linked to numerous diseases. Recent findings include the identification of critical proteins such as Src and Ras, which are involved in cancer progression, as well as GP160, associated with HIV. His lab develops innovative methods for detecting acylated proteins, contributing to advancements in chemical biology aimed at understanding signal transduction pathways and mitochondrial metabolism regulation. His work has resulted in potential therapeutic developments for blood cancer cells vulnerable to myristoylation inhibitors, leading to the establishment of a pharmaceutical company, PACYLEX Pharmaceuticals Inc. His lab is also affiliated with the Cancer Research Institute of Northern Alberta, underlining a commitment to translating research findings into clinical applications for cancer treatment.
University of Alberta • Edmonton, AB, Canada
Teaching and researching in the field of Cell Biology with a focus on protein fatty acylation and its implications in cancer biology.
Department: Mechanical Engineering and Engineering Management